All News

Partnering

Cellectis and AstraZeneca Forge Innovative Partnership to Pioneer Next-Generation Therapeutics
1 November 2023
Cellectis and AstraZeneca Forge Innovative Partnership to Pioneer Next-Generation Therapeutics
Cellectis announces its collaboration with
Verve and Lilly’s Partnership Expands to Include Verve’s in vivo Gene Editing Programs
1 November 2023
Verve and Lilly’s Partnership Expands to Include Verve’s in vivo Gene Editing Programs
Verve and Lilly's partnership expands
Bristol Myers Squibb to Acquire Mirati Therapeutics in $4.8 Billion Deal
11 October 2023
Bristol Myers Squibb to Acquire Mirati Therapeutics in $4.8 Billion Deal
Bristol Myers Squibb to is
Orchard Therapeutics to be Acquired by Kyowa Kirin
5 October 2023
Orchard Therapeutics to be Acquired by Kyowa Kirin
Kyowa Kirin is to acquire
POPULAR NEWS ITEMS
Image
4 December 2023

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image
6 December 2023

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image
5 December 2023

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome

Precision BioSciences Completes Strategic $227M Transaction with Imugene for CAR-T Therapy
17 August 2023
Precision BioSciences Completes Strategic $227M Transaction with Imugene for CAR-T Therapy
Precision BioSciences Completes Strategic Transaction
RenovoRx and Imugene Collaborate to Deliver Oncolytic Virus Therapy Using Proprietary Platform
21 July 2023
RenovoRx and Imugene Collaborate to Deliver Oncolytic Virus Therapy Using Proprietary Platform
RenovoRx and Imugene announce their
Vertex and Lonza Unite to Build Dedicated Facility for Type 1 Diabetes Cell Therapies
27 June 2023
Vertex and Lonza Unite to Build Dedicated Facility for Type 1 Diabetes Cell Therapies
Vertex and Lonza announce strategic
Anthony Nolan and MicrofluidX Partner to Revolutionize the Development of Cell and Gene Therapies
23 June 2023
Anthony Nolan and MicrofluidX Partner to Revolutionize the Development of Cell and Gene Therapies
MicrofluidX will be testing its
Load more News
RECOMENDED TOPICS
Automation & Digitisation
Characterisation
CMC
GMP
Logistics
Partnering
Point of Care
Raw Materials
Scaling Up
Skills, Talent & Development
Supply Chain
POPULAR NEWS ITEMS
Image

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome